Paper Details

  1. Home
  2. Paper Details

Solifenacin at 3 years: a review of efficacy and safety.

Author: CapoJames P, Forero-SchwanhaeuserSergio, PelmanRichard S

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Solifenacin, a once-daily antimuscarinic agent for overactive bladder (OAB), has been shown to be safe and effective in treating incontinence, urgency, and other OAB symptoms in over 2.2 million patients worldwide. Clinical trials demonstrated its superiority to placebo and tolterodine ER, with good tolerability and a low incidence of side effects. Solifenacin provides 24-hour control of OAB symptoms and increases warning time, potentially reducing incontinence episodes.
Paper Details　
Original Abstract of the Article :
Now on the market in the United States for almost 3 years and available in 48 countries worldwide, solifenacin 5 mg or 10 mg once daily continues to demonstrate a profile of safety and efficacy as a treatment for incontinence, urgency, and other symptoms of OAB. More than 2.2 million patients have b...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.3810/pgm.2008.07.1795

データ提供：米国国立医学図書館（NLM）

Solifenacin: A Promising Treatment for Overactive Bladder

The desert of urinary health can be a challenging place to navigate, with symptoms like incontinence and urgency often causing distress. This research explores the effectiveness and safety of solifenacin, a medication used to treat overactive bladder (OAB), seeking to provide relief for those seeking a more manageable journey in the desert of urinary health.

Solifenacin, a medication available worldwide, has demonstrated both safety and efficacy in treating incontinence, urgency, and other symptoms of OAB. This research reviewed data from numerous studies involving thousands of patients, highlighting the benefits of solifenacin as a first-line treatment for OAB. The researchers found that solifenacin was significantly more effective than placebo and even outperformed tolterodine, another commonly used medication for OAB. Furthermore, solifenacin was found to be well tolerated with a low incidence of side effects. It's like finding a cool, refreshing spring in the middle of a scorching desert - solifenacin offers a much-needed respite from the challenges of OAB.

A New Hope for Overactive Bladder

This research offers promising news for individuals struggling with OAB, demonstrating the effectiveness and safety of solifenacin in providing relief from symptoms. This medication is like a beacon of hope, guiding those navigating the challenging terrain of OAB towards a more manageable journey.

Managing Overactive Bladder Symptoms

For those seeking relief from OAB symptoms, solifenacin could be a valuable tool in their journey toward a more comfortable and confident lifestyle.

Dr. Camel's Conclusion

This review of solifenacin's efficacy and safety provides encouraging evidence for those seeking relief from the challenges of overactive bladder. This research is like an oasis in the desert of urinary health, offering hope and practical solutions for managing OAB symptoms. The findings suggest that solifenacin can be a valuable tool for improving the lives of individuals struggling with OAB, offering a more comfortable and confident journey through the desert of urinary health.

Date :
  1. Date Completed 2008-10-21
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

18654073

DOI: Digital Object Identifier

10.3810/pgm.2008.07.1795

Related Literature

Article Analysis
・Side Effects of tolterodine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.